Loading
Latest filing published 02 Oct 2026 for InnoCare Pharma Ltd..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zhao Renbin discloses dealings in InnoCare Pharma Ltd. to HKEX. We count 24 filings; the first trade dates from 3 June 2020 and the latest from 30 September 2026.
The open-market side counts 6 purchases alongside 9 sales for €158k. The amount is not disclosed for 14 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 3 purchases and 4 sales.
None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 2 October 2026 came the latest disclosure, an open-market sale in InnoCare Pharma Ltd. The last insider purchase was made public on 23 June 2026, 123 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations